Cutaneous drug eruptions associated with COVID-19 therapy
Saved in:
Main Authors: | Laura Atzori, MD (Author), Stefania Perla, MD (Author), Maria Giovanna Atzori, MD (Author), Caterina Ferreli, MD (Author), Franco Rongioletti, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glomeruloid reactive angioendotheliomatosis in a woman with systemic lupus erythematosus and antiphospholipid syndrome mimicking reticular erythematous mucinosis
by: Caterina Ferreli, MD, et al.
Published: (2021) -
Don't forget about syphilis: sexually transmitted diseases during COVID-19 pandemic
by: Andrea Di Buduo, et al.
Published: (2020) -
Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition
by: Laura Atzori, et al.
Published: (2021) -
Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
by: Laura Pizzatti, MD, et al.
Published: (2020) -
Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine
by: Giovanni Paolino, MD, PhD, et al.
Published: (2022)